Shanghai, China

Qin Bao


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Qin Bao

Introduction

Qin Bao is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on regadenoson. His research has implications for improving medical imaging techniques, showcasing his commitment to advancing healthcare solutions.

Latest Patents

Qin Bao holds a patent for a new crystal form of regadenoson, specifically crystal form E. This invention is crucial as it offers excellent performance in radionuclide myocardial perfusion imaging. The crystal form E is characterized by its low toxicity and good storage stability, making it suitable for use as a stress agent in medical imaging procedures.

Career Highlights

Qin Bao is associated with Shanghai Ziyuan Pharmaceutical Co., Ltd., where he continues to contribute to pharmaceutical innovations. His work has not only advanced the understanding of regadenoson but has also paved the way for new applications in medical diagnostics.

Collaborations

He collaborates with esteemed colleagues such as Yu Wang and Zhigang Zhang, further enhancing the research and development efforts within his field.

Conclusion

Qin Bao's contributions to medicinal chemistry, particularly through his patent on regadenoson, highlight his role as an influential inventor in the pharmaceutical industry. His work continues to impact medical imaging and patient care positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…